Croatia

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

J&J says it has “exhausted all current viable avenues” to get its antidepressant nasal spray Spravato reimbursed on England’s National Health Service, after NICE decided against re-appraising the drug following numerous funding rejections.

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.  

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

The latest notified body listing brings total number of EU designated Medical Device Regulation testing and certification organizations to 35.

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

The latest update in the Medical Device Regulation page of the European Commission's Nando database represents the 18th listing under the new regulation. Numbers are rising slowly.

One more name has appeared in the European Commission list of notified bodies designated under the MDR and marks the the first time a Croatian company has been appointed. This time, the fanfare has been overshadowed by frustration from the industry as EU medtech regulation deadlines approach.

PharmaS has struck a deal with Atlantic Grupa which will see it acquire Croatia's leading dietary supplement brand, as well as a product particularly popular with Russian consumers. 

Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

Marketing each other’s product portfolio and collaborating on production of preservative-free ophthalmics are central facets of a broad alliance struck between Poland’s Polpharma and Croatia’s JGL.  

Polphama and JGL have struck a deal to distribute one another's ophthalmology products, PharmaNutra has secured expanded distribution for its Cetilar joint pain product, and Bionorica has offloaded its cannabis business to Canada's Canopy.

The Valletta group of southern EU states on improving access to medicines continues to expand and now includes Croatia.

Question: What's the difference between these two statements? 1) "Resistance to antibiotics and other anti-infective agents constitutes a major threat to public health." 2) "Antimicrobial resistance is a serious public health threat."

Question: What's the difference between these two statements? 1) "Resistance to antibiotics and other anti-infective agents constitutes a major threat to public health." 2) "Antimicrobial resistance is a serious public health threat."

The European Medicines Agency is asking all pharmaceutical companies with medicines approved under the European Union's centralised procedure to start translating their product information into the Croatian language as the Balkan state prepares to join the EU on 1 June 2012.

GlaxoSmithKline has appointed a former Goldman Sachs managing director and partner to replace its chief financial officer Julian Heslop.